Pauls Matthew sold PTHS
October 2, 2026 · Form 4 insider transaction
Pauls Matthew sold 786 shares of Pelthos Therapeutics Inc. at $21.00 per share, a transaction worth $16.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
786
Price
$21.00
Total value
$16.5K
InsiderPauls Matthew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2026
Filing dateOctober 6, 2026
Shares owned after13,578
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.